CIK 0000073290 · Non-accelerated filer<br>Smaller reporting company
BIOMERICA INC
Sign in to watch- Ticker
- BMRA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 952645573
- Phone
- 9493792875
- Business address
- 17571 VON KARMAN AVENUE, IRVINE, CA, 92614
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q/A Report 10-Q/A
- 10-Q Report Quarterly Report
- 8-K Event Shareholder vote results
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 4 Open-market sale President sold 15,000 shares at $2.46 ($36,830)
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
- 4 Option exercise Director acquired 25,000 shares (option exercise)
Page 14 of 31 · 605 filings